ESTRO 38 - Programme Book & Exhibition Guide

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

SATURDAY 27 APRIL 2019

09:21 > RBE of protons: what can we learn from preclinical models? C.P. Karger (Germany) 09:39 > Dynamics changes in immune cells during glioblastoma response to treatment: macrophages at play Speaker: L. Akkari (The Netherlands) SYMPOSIUM Optimal management of patients with unresectable stage 3 NSCLC 08:45 - 10:00 | Gold Plenary Chair: U. Nestle (Germany) Co-chair: C. Ostheimer (Germany) 09:03 > Optimal management of patients with unresectable stage III NSCLC: areas of controversy and ongoing research Speaker: R. Dziadziuszko (Poland) 09:21 > Active management of patient’s comorbidities (including respiratory and cardiac comorbidities) Speaker: V. Westeel (France) 09:39 > Role of patient reported outcome in patients follow-up Speaker: Y. Lievens (Belgium) SYMPOSIUM Combined modality treatment vs chemotherapy alone in lymphoma patients? 08:45 - 10:00 | Brown 3 The session will consist of two main parts – in the first one, speakers will deliver lectures regarding the current state of art and the role of radiation therapy in Hodgkin lymphomas (Prof. Eich) and indolent lymphomas (Prof. Yahalom). The second part of the session will discuss the role of combined modality treatment versus chemotherapy alone in the treatment of aggressive lymphomas (DLBCL) from a radiation oncologist view (Prof. Mikhaeel) and a haematologist view (Prof. Vitolo). After the lectures time for audience discussion (15 minutes) is also provided. 08:45 > Standard of care in 2019 Speaker: F. McDonald (United Kingdom)

SP-0015

SP-0016

SP-0017

SP-0018

SP-0019

SP-0020

Chair: U. Ricardi (Italy) Co-chair: B. Tomasik (Poland)

Programme and Exhibition Guide | SCIENTIFIC PROGRAMME

77